ÃÖÁ¾ÆíÁýÀÏ03.28 17:33
°Ë»öÇϱâ
ÀαâmouGEÇÐȸ

[Á¦¾à/À¯Åë > Á¦¾à]

´ë¿õÁ¦¾à ¡®³ªº¸Å¸¡¯ ³²¼ºÇü Å»¸ð¿¡ È¿°ú ÀÔÁõ

ÀÓ»ó, µÎÇÇÅõ¿© 6°³¿ù¸¸¿¡ ¸ð¹ß°¹¼ö Åë°èÀûÀ¸·Î À¯ÀÇ Áõ°¡
±è¿µ±æ±âÀÚ/pharmakr@naver.com
½ÂÀÎ 20-11-26 06:41 | ÃÖÁ¾¼öÁ¤ 20-11-27 05:29  
 

SCI, Ú¸ ÇǺΰúÇÐȸÁö-JAAD 12¿ùÈ£ ¿¬±¸³»¿ë °ÔÀç
´Ü±¹´ë¼­ È¿°ú¼º °³¼±ÇÑ Åõ¿© ¿ä¹ý µî Ãß°¡ ÀÓ»ó Áß

                

  ¡ãÅ»¸ð ºÎÀ§¿¡ ³ªº¸Å¸ ÁÖ»ç Àü(A)°ú ÁÖ»ç ÈÄ 24ÁÖÂ÷(B)ÀÇ ¿¬±¸ÀÚ À°¾È Æò°¡.(Visual evaluation of 24 weeks after Nabota injection )

 

´ë¿õÁ¦¾àÀÌ ÀÚü °³¹ßÇÑ º¸Åø¸®´® Åå½Å Á¦Á¦ ¡®³ªº¸Å¸¡¯°¡ ³²¼ºÇü Å»¸ð Ä¡·á¹ýÀÌ µÉ ¼ö ÀÖ´Ù´Â ±Ù°Å°¡ ¸¶·ÃµÆ´Ù.(ÇÏ´Ü¿¡ ¿µ¹® Á¦¸ñ ¹× ±â»ç ÀÖ½À´Ï´Ù).

 

26ÀÏ ´ë¿õÁ¦¾à(´ëÇ¥ Àü½ÂÈ£)Àº ³ªº¸Å¸ÀÇ Å»¸ð °³¼± È¿°ú¿¡ ´ëÇÑ ¿¬±¸ÀÚÀÓ»ó ¿¬±¸ °á°ú°¡ SCI Àú³ÎÀÎ ¹Ì±¹ÇǺΰúÇÐȸÁö(Journal of the American Academy of Dermatology, JAAD) 12¿ùÈ£¿¡ °ÔÀçµÈ´Ù°í ¹àÇû´Ù.

JAAD´Â ÇǺΰúÇÐ °ü·Ã ºÐ¾ß¿¡¼­ ¿µÇâ·Â Áö¼ö(Impact Factor)°¡ ³ôÀº Àú³Î·Î ²ÅÈù´Ù.

 

À̹ø ¿¬±¸´Â ³²¼ºÇü Å»¸ð¿¡¼­ÀÇ º¸Åø¸®´® Åå½ÅÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» È®ÀÎÇϱâ À§ÇÑ ¸ñÀûÀ¸·Î ÁøÇàµÆ´Ù. ¿¬±¸ÁøÀº Å»¸ð ºÎÀ§¿¡ ¾à 20 ±ºµ¥ ½Ã¼ú ¹üÀ§¸¦ ¼³Á¤ÇÑ ÈÄ ³ªº¸Å¸¸¦ 4ÁÖ °£°ÝÀ¸·Î ÃÑ 6ȸ Åõ¿©Çß´Ù. 1ȸ Åõ¿© ½Ã 30À¯´Ö(U)¸¦ ÁÖ»çÇßÀ¸¸ç, 24ÁÖ°£ ÃÑ 180À¯´Ö(U)À» ÁÖ»çÇß´Ù.
 
±× °á°ú Ä¡·á Àü°ú ´ëºñÇØ 24ÁÖÂ÷¿¡ ¸ð¹ß °³¼ö°¡ Åë°èÀûÀ¸·Î À¯ÀÇÇÏ°Ô Áõ°¡Çß´Ù. ¶ÇÇÑ, ¿¬±¸ÀÚÀÇ À°¾È Æò°¡(Physician¡¯s global assessment scale)¿¡¼­µµ Åë°èÀûÀ¸·Î À¯ÀÇÇÏ°Ô Å»¸ð°¡ °³¼±µÈ °ÍÀ» È®ÀÎÇß´Ù. ¾à¹° °ü·Ã ½É°¢ÇÑ ÀÌ»ó»ç·Ê´Â º¸°íµÇÁö ¾Ê¾Ò´Ù.

 

¿¬±¸¸¦ ÁøÇàÇÑ ¹Úº´Ã¶ ´Ü±¹´ëÇб³ ÇǺΰú ±³¼ö´Â ¼±Ç࿬±¸¸¦ ÅëÇØ ³ªº¸Å¸°¡ ¸ð³¶¼¼Æ÷¿¡¼­ ¸ð³¶ÀÇ ÈÞÁö±â À¯µµ ¹× Å»¸ð¸¦ À¯¹ß½ÃÅ°´Â TGF-¥â1ÀÇ ºÐºñ¸¦ ¾ïÁ¦ÇÏ´Â È¿°ú°¡ ÀÖÀ½À» È®ÀÎÇÑ ¹Ù ÀÖ´Ù.

 

¹Ú ±³¼ö´Â ¡°º¸Åø¸®´® Åå½ÅÀÇ ÁøÇÇ ¸ð³¶ Áֻ翡 ÀÇÇØ TGF-¥â1ÀÌ ¾ïÁ¦µÊÀ¸·Î½á »ýÀå±â ¸ð¹ßÀÇ ±â°£ÀÌ ¿¬ÀåµÇ°í, ÈÞÁö±â ¸ð¹ß Å»¶ôÀÌ ¾ïÁ¦µÅ Å»¸ð°¡ °¨¼ÒÇÏ°í ¸ð¹ß·®ÀÌ Áõ°¡ÇÑ °ÍÀ¸·Î º¸Àδ١±¸ç ¡°À̹ø ¿¬±¸´Â ³²¼ºÇü Å»¸ð¿¡ º¸Åø¸®´® Åå½ÅÀÌ ÇϳªÀÇ Ä¡·á¹ýÀÌ µÉ ¼ö ÀÖ´Ù´Â ±Ù°Å¸¦ ¸¶·ÃÇß´Ù´Â Á¡°ú ±× Ä¡·á ¸ÞÄ¿´ÏÁòÀ» °úÇÐÀûÀ¸·Î ºÐ¼®Çß´Ù´Â µ¥ Àǹ̰¡ ÀÖ´Ù¡±¶ó°í ¹àÇû´Ù.

 

¹Ú¼º¼ö ´ë¿õÁ¦¾à ³ªº¸Å¸ »ç¾÷º»ºÎÀåÀº ¡°³ªº¸Å¸ÀÇ ³²¼ºÇü Å»¸ð¿¡ ´ëÇÑ ÀÓ»ó ¿¬±¸ °á°ú°¡ ±ÇÀ§ÀÖ´Â ±¹Á¦ÇмúÁö¿¡ µîÀçµÊÀ¸·Î½á ³ªº¸Å¸ÀÇ Â÷º°È­µÈ °æÀï·ÂÀ» ´õ¿í °­È­ÇÏ´Â °è±â°¡ µÆ´Ù¡±¸ç ¡°±î´Ù·Î¿î ¹Ì±¹, À¯·´, ij³ª´Ù µî ¼±Áø±¹ ±ÔÁ¦±â°üÀ¸·ÎºÎÅÍ ÀÎÁ¤¹ÞÀº ¿ì¼öÇÑ Á¦Ç°·ÂÀ» ¹ÙÅÁÀ¸·Î ¾ÕÀ¸·Îµµ ´Ù¾çÇÑ ¿¬±¸¸¦ ÅëÇØ ±Û·Î¹ú ºê·£µå·Î¼­ÀÇ À§»óÀ» °ø°íÈ÷ ´ÙÁ®³ª°¡°Ú´Ù¡±°í ¸»Çß´Ù.

 

ÇÑÆí, ¹Úº´Ã¶ ±³¼ö ¿¬±¸ÆÀ(´Ü±¹´ëÇб³ ±âÃÊ ¹× ÀÓ»ó ¸ð¹ß ¿¬±¸¼Ò)Àº ³²¼ºÇü Å»¸ðȯÀÚ¿¡°Ô Åõ¿©°£°ÝÀ» 3°³¿ù·Î ´Ã¸®°í 1ȸ ¸ð³¶ ÁÖ»ç ½Ã ³ªº¸Å¸ÀÇ ¿ë·®À» Áõ·®ÇØ Å»¸ð¿¡ ´ëÇÑ ´õ È¿°ú ÁÁ°í Æí¸®ÇÑ Åõ¿©¹æ¹ýÀ» È®ÀÎÇÏ´Â Èıâ ÀÓ»ó 2»ó ¿¬±¸¸¦ ÁøÇà Áß ÀÌ´Ù

-----------------------------------------------------------------------------

<¾Æ·¡ ¿µ¹®±â»ç ÀÖ½À´Ï´Ù/ÀÛ¼º ±è¿µ±æ ±âÀÚ>


Dae Woong Pharm. 'NABOTA' effective for male alopecia

   

Clinical Study showed statistically significant improvement in the number of hair

growing after six month's scalp injection.

 

The research content was filled in the December Edit of the American Journal - JAAD

 

On the way of supplementary studies including an administering method with the improved efficacy

 

The treatment of male alopecia was established by the Botulinum preparation developed by Dae Woon Pharm. by itself.

 

Dae Woong Pharm (CEO Jeon, Seung Ho) announced that the result of the improved efficacy of Nabota for the male alopecia was filled in the SCI journal, December edit of JAAD.

 

JAAD has been considered that the influence in the skin science fields was very high in its impact factor.

 

This research has been performed in order to secure the efficacy and safety of the botulinum toxin for male alopecia. The research team set up the 20 spots of applications on the alopecic sites and applied total 6 times every 4 weeks. There were 30 units at one injection and 180 units for 24 weeks.

   

In the result, there were statistically significant increasing figures in hair before and after the treatment. And also it has been proved that the improvement of the alopecia treatment was recognized on the physician's global assessment scale by the research team. There was no side effect appeared.

 

Professor Park said that the hair growing period was extended through the inhibition of TGF-beta1 by the corium injection of botulinum toxin, and the hair pause period was decreased to reduce the alopecia resulting in the increment of hairs. It has been clarified that the botulinum toxin could be a treatment for the male alopecia and also it is meaningful that the treatment mechanism has been analyzed by the scientific method.

 

Mr. Park, Seong Soo, Nabota business administrator of Dae Woon Pharm. said that the clinical research result for the male alopecia by Nabota has been filled on the internationally recognized journal and which became a good chance for strengthening the Nabota's distinctive competitiveness.

 

And also he said he would be going to elevate its status as a global brand through the diversified researches in the future based upon the brand names recognized by advanced countries' regulation organizations such as USA, Europe, Canada and so on.

 

On the other way, the research study group of professor Park, Byeong Cheol belonging to the Hair Research Center for the basic and clinical study is going on the post clinical phase II for identifying the better efficacy and easy administration through the experiments of increasing the injection interval by three months and adding the injection amount a little bit more than before. 

 

 
 
Copyright¨Ï»çÀ̾𽺿¥µð´º½º ¹«´Ü ÀüÀç ¹× Àç¹èÆ÷ ±ÝÁö
   
 
 
 
 
³×ƼÁð ÀÇ°ß(0)
³»¿ë ¾ÆÀ̵ð ÀÛ¼ºÀÏ
 
ÀÇ°ßÀÛ¼ºÇϱâ
 
 
À̸§ ºñ¹Ð¹øÈ£
 
Á¦ÀÏÇコ»çÀ̾ð½º, üÁö¹æ '½ëÆ®Èú °¼¸£½Ã´Ï¾Æ' Ãâ½Ã
AZ.³ë¹ÙƼ½º, Æ÷½Ã°¡-°¡ºê½º ƯÇãºÐÀï ´ë¹ý¿øÇà
Á¦¾à ±â»ç¸ñ·Ï º¸±â
 
Àαⴺ½º
´ç´¢º´ Ä¡·áÁ¦, ³úÁ¹Áß ¿¹¹æ¿¡..
½É³úÇ÷°ü ¹ß»ý, ±Ô¸ð ÃßÁ¤ ¾Ë..
GC³ì½ÊÀÚÀÇ·áÀç´Ü, ±¹³» ÀÓ»ó..
ÀÇ·á±â±âÁ¶ÇÕ, TUV Rheinland ..
IVI, Àεµ ¹ÙÀÌ¿À·ÎÁöÄà E»ç¿¡..
 
¸¹ÀÌ º» Æ÷Åä´º½º
ÀÇÁ¤ºÎÀ»Áö´ëº´¿ø ¡®Ã£¾Æ°¡´Â ..
ÇÏÀ̷δÐ, ¸¶½ºÅÏ-EDCÞä µî°ú ..
±æ¸®¾îµå, ¿¬¼¼¾Ïº´¿ø°ú Ç×¾Ï..
"¿ì·ç»ç' ´ë¿õ ÀÓÁ÷¿ø Âü¿© '..
 
ÃֽŠÀαⴺ½º
½É³úÇ÷°ü ¹ß»ý, ±Ô¸ð ÃßÁ¤ ¾Ë..
GC³ì½ÊÀÚÀÇ·áÀç´Ü, ±¹³» ÀÓ»ó..
³»´Þ, Ò´ 800¾ï ó¹æ Ç÷¡¸®½º..
´ë¿õ, ¾çµµ-¾ç¼ö·Î Æ÷½Ã°¡ 'µ¶..
Çѱ¹´ÙÄÉ´ÙÁ¦¾à, ¼¼°è ½ÉÀå Àü..